Drug Discovery World

APRIL 3, 2023

This project still acts as a robust proof-of-concept for the potential of our technology in diagnostics and as assay reagents. DS: You operate a pretty high-tech laboratory, giving you a quick turnaround time. Does the use of automation allow the company to maintain lower staff levels?

Antibody 52

Antibody Gene Therapy Gene In-Vitro 52

Roots Analysis

FEBRUARY 13, 2023

Further, the biggest challenge in this domain is the purification which involve the use of hazardous solvents / materials and stability of drug products ( thereby, requiring specialized facilities and cold chain transportation).

Manufacturing 52

Manufacturing Drug Delivery Systems Genetic Engineering RNA 52

Pharmaceutical Technology

FEBRUARY 15, 2023

“At the small scale, manufacturing between 1 ml and 10 ml is typically not problematic , but it’s not straightforward to replicate processes and technologies once you want to produce tens of litres of formulations,” says Dr Crowe, who manages a team that develop novel analytical assays related to LNPs and nanomaterials for drug delivery.

Bioassay 130

Bioassay Development RNA Drugs 130

XTalks

OCTOBER 1, 2020

Xtalks spoke with WeiQi Lin, MD, PhD, executive vice president, research & development, and principal scientist at DURECT Corporation — a company focused on developing drugs and drug delivery methods in therapeutic areas with significant unmet need — about her transition from academia to industry.

Scientist 52

Scientist In-Vitro Research Life Science 52